Literature DB >> 17664529

CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells.

J Mark Brown1, Soonkyu Chung, Akash Das, Gregory S Shelness, Lawrence L Rudel, Liqing Yu.   

Abstract

Comparative Gene Identification-58 (CGI-58) is a member of the alpha/beta-hydrolase family of proteins. Mutations in the human CGI-58 gene are associated with Chanarin-Dorfman syndrome, a rare autosomal recessive genetic disease in which excessive triglyceride (TG) accumulation occurs in multiple tissues. In this study, we investigated the role of CGI-58 in cellular lipid metabolism in several cell models and discovered a role for CGI-58 in promoting the packaging of cytoplasmic TG into secreted lipoprotein particles in hepatoma cells. Using both gain-of-function and loss-of-function approaches, we demonstrate that CGI-58 facilitates the depletion of cellular TG stores without altering cellular cholesterol or phospholipid accumulation. This depletion of cellular TG is attributable solely to augmented hydrolysis, whereas TG synthesis was not affected by CGI-58. Furthermore, CGI-58-mediated TG hydrolysis can be completely inhibited by the known lipase inhibitors diethylumbelliferyl phosphate and diethyl-p-nitrophenyl phosphate, but not by p-chloro-mercuribenzoate. Intriguingly, CGI-58-driven TG hydrolysis was coupled to increases in both fatty acid oxidation and secretion of TG. Collectively, this study reveals a role for CGI-58 in coupling lipolytic degradation of cytoplasmic TG to oxidation and packaging into TG-rich lipoproteins for secretion in hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664529     DOI: 10.1194/jlr.M700279-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation.

Authors:  Caleb C Lord; Daniel Ferguson; Gwynneth Thomas; Amanda L Brown; Rebecca C Schugar; Amy Burrows; Anthony D Gromovsky; Jenna Betters; Chase Neumann; Jessica Sacks; Stephanie Marshall; Russell Watts; Martina Schweiger; Richard G Lee; Rosanne M Crooke; Mark J Graham; Justin D Lathia; Takuya F Sakaguchi; Richard Lehner; Guenter Haemmerle; Rudolf Zechner; J Mark Brown
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  ABHD5/CGI-58 facilitates the assembly and secretion of apolipoprotein B lipoproteins by McA RH7777 rat hepatoma cells.

Authors:  Jorge M Caviglia; Janet D Sparks; Nikhil Toraskar; Anita M Brinker; Terry C Yin; Joseph L Dixon; Dawn L Brasaemle
Journal:  Biochim Biophys Acta       Date:  2009-01-13

3.  Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity.

Authors:  Jorge M Caviglia; Jenna L Betters; Dianne-Helerie Dapito; Caleb C Lord; Sean Sullivan; Streamson Chua; Terry Yin; Anna Sekowski; Haiyan Mu; Lawrence Shapiro; J Mark Brown; Dawn L Brasaemle
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

4.  Muscle-specific deletion of comparative gene identification-58 (CGI-58) causes muscle steatosis but improves insulin sensitivity in male mice.

Authors:  Ping Xie; Anil K G Kadegowda; Yinyan Ma; Feng Guo; Xianlin Han; Miao Wang; Leanne Groban; Bingzhong Xue; Hang Shi; Huihua Li; Liqing Yu
Journal:  Endocrinology       Date:  2015-03-09       Impact factor: 4.736

Review 5.  CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

Authors:  Liqing Yu; Yi Li; Alison Grisé; Huan Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 6.  Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.

Authors:  Amanda L Brown; J Mark Brown
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-08-04       Impact factor: 4.698

7.  Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58).

Authors:  Franz P W Radner; Ingo E Streith; Gabriele Schoiswohl; Martina Schweiger; Manju Kumari; Thomas O Eichmann; Gerald Rechberger; Harald C Koefeler; Sandra Eder; Silvia Schauer; H Christian Theussl; Karina Preiss-Landl; Achim Lass; Robert Zimmermann; Gerald Hoefler; Rudolf Zechner; Guenter Haemmerle
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Novel Pharmacological Probes Reveal ABHD5 as a Locus of Lipolysis Control in White and Brown Adipocytes.

Authors:  Elizabeth A Rondini; Ljiljana Mladenovic-Lucas; William R Roush; Geoff T Halvorsen; Alex E Green; James G Granneman
Journal:  J Pharmacol Exp Ther       Date:  2017-09-19       Impact factor: 4.030

9.  Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.

Authors:  Juanjuan Ou; Hongming Miao; Yinyan Ma; Feng Guo; Jia Deng; Xing Wei; Jie Zhou; Ganfeng Xie; Hang Shi; Bingzhong Xue; Houjie Liang; Liqing Yu
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

10.  Arylacetamide deacetylase attenuates fatty-acid-induced triacylglycerol accumulation in rat hepatoma cells.

Authors:  Vivien Lo; Bruce Erickson; Michaela Thomason-Hughes; Kerry W S Ko; Vernon W Dolinsky; Randy Nelson; Richard Lehner
Journal:  J Lipid Res       Date:  2009-08-04       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.